After an infant last year was saved from a deadly disease thanks to a bespoke gene editing therapy that fixed an incredibly rare mutation in his DNA, the US government is hoping …
Source: Endpoints News
You may also like
Macrophage Membrane-Derived Nanoparticles Shows...
Stem Cell Therapy Shows Promise in First Human...
Ag Genomics Begins to Bear Fruit
StockWatch: Insilico Projects Profit, Revenue Leaps as...
[Podcast] From Protocol to Patient: Inside Clinical...
KKR-backed Allyntra debuts to serve medtech industry...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.